T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNR
1901
Core Natural Resources Inc
CNR
$4.69B
| $851K | ﹤0.01% |
31,984
+5,000
| +19% | +$150K |
|
1902
Materion
MTRN
$5.93B
| $847K | ﹤0.01% |
12,485
+53
| +0.4% | +$3.34K |
|
1903
Simulations Plus
SLP
$371M
| $846K | ﹤0.01% |
29,612
+2,714
| +10% | +$65.8K |
|
1904
LXP Industrial Trust
LXP
$3.58B
| $844K | ﹤0.01% |
17,929
+150
| +0.8% | +$6.92K |
|
|
ESGR
1905
DELISTED
Enstar Group
ESGR
| $841K | ﹤0.01% |
4,823
+20
| +0.4% | +$3.47K |
|
1906
Oil States International
OIS
$538M
| $839K | ﹤0.01% |
45,867
+131
| +0.3% | +$2.35K |
|
|
FMBI
1907
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $838K | ﹤0.01% |
40,949
+162
| +0.4% | +$3.35K |
|
|
EGRX
1908
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $836K | ﹤0.01% |
15,022
+20
| +0.1% | +$1.04K |
|
|
AEL
1909
DELISTED
American Equity Investment Life Holding Company
AEL
| $827K | ﹤0.01% |
30,447
+187
| +0.6% | +$5.35K |
|
1910
iShares MSCI Japan ETF
EWJ
$23.3B
| $826K | ﹤0.01% |
15,125
+6,800
| +82% | +$370K |
|
1911
H.B. Fuller
FUL
$3.25B
| $826K | ﹤0.01% |
17,794
+129
| +0.7% | +$5.95K |
|
1912
La-Z-Boy
LZB
$1.67B
| $826K | ﹤0.01% |
26,938
+217
| +0.8% | +$7.08K |
|
|
BHVN
1913
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $825K | ﹤0.01% |
+18,831
| New | +$1.06M |
|
1914
Glaukos
GKOS
$11B
| $823K | ﹤0.01% |
10,915
-1,114,787
| -99% | -$80M |
|
1915
ABM Industries
ABM
$2.83B
| $820K | ﹤0.01% |
20,504
+170
| +0.8% | +$6.46K |
|
|
HEES
1916
DELISTED
H&E Equipment Services
HEES
| $820K | ﹤0.01% |
28,196
+16
| +0.1% | +$445 |
|
1917
Wolverine World Wide
WWW
$1.63B
| $820K | ﹤0.01% |
29,780
+233
| +0.8% | +$7.41K |
|
|
GOOD
1918
Gladstone Commercial Corp
GOOD
$633M
| $817K | ﹤0.01% |
38,518
+39
| +0.1% | +$829 |
|
1919
Dave & Buster's
PLAY
$373M
| $814K | ﹤0.01% |
20,107
+69
| +0.3% | +$3.51K |
|
1920
CNX Resources
CNX
$5.24B
| $811K | ﹤0.01% |
110,985
+1,071
| +1% | +$9.41K |
|
|
HTLF
1921
DELISTED
Heartland Financial USA, Inc.
HTLF
| $810K | ﹤0.01% |
18,112
+3,128
| +21% | +$138K |
|
|
PEI
1922
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $810K | ﹤0.01% |
8,304
+7
| +0.1% | +$681 |
|
1923
TFS Financial
TFSL
$4.94B
| $806K | ﹤0.01% |
44,580
+797
| +2% | +$13.6K |
|
1924
Kulicke & Soffa
KLIC
$5.03B
| $805K | ﹤0.01% |
35,700
| – | – |
|
1925
Scansource
SCSC
$1.07B
| $800K | ﹤0.01% |
24,584
+74
| +0.3% | +$2.52K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.